Evidence map›Paper›PMID 35089927›Full record

ArticlePLoS neglected tropical diseases2022

Development of a simple, rapid, and sensitive diagnostic assay for enterotoxigenic E. coli and Shigella spp applicable to endemic countries.

Subhra Chakraborty, Sean Connor, Mirza Velagic

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07433426 (The Impact of Shigellosis and Recommended Treatment in Children), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07433426 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

The Impact of Shigellosis and Recommended Treatment in Children

TypeinterventionalSponsorJohns Hopkins Bloomberg School of Public HealthRan2026 to 2030Enrolled700ConditionsDiarrhea Infectious, Shigella, Growth & DevelopmentArmsAzithromycin, Placebo
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. The Burden and Genomic Characterization ofmedRxiv : the preprint server for health sciences · 2026
    Article
  4. Article
  5. Review
  6. Evaluation of the performance and feasibility of RLDT in detectingmedRxiv : the preprint server for health sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Clinical Prediction Rule to Guide Diagnostic Testing forOpen forum infectious diseases · 2023
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Subhra ChakrabortyDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID 0000-0002-6446-0255
Sean ConnorDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Mirza VelagicDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID 0000-0003-1404-3688
Johns Hopkins University · US

Funding

Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban communityR01AI108695 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CHAKRABORTY, SUBHRA, GILMAN, ROBERT H · 2015 to 2019
$5.0M
A novel diagnostic tool to aid vaccine evaluation and surveillance of enterotoxigenic E. coli and ShigellaR21AI137804 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CHAKRABORTY, SUBHRA · 2018 to 2019
$368k
NIAID NIH HHS R01 AI108695NIAID NIH HHS R21 AI137804
6 · The paper itself

Abstract

Enterotoxigenic E. coli (ETEC) and Shigella spp (Shigella) are complex pathogens. The diagnostic assays currently used to detect these pathogens are elaborate or complicated, which make them difficult to apply in resource poor settings where these diseases are endemic. The culture methods used to detect Shigella are not sensitive, and the methods used to detect ETEC are only available in a few research labs. To address this gap, we developed a rapid and simple diagnostic assay-"Rapid LAMP based Diagnostic Test (RLDT)." The six minutes sample preparation method directly from the fecal samples with lyophilized reaction strips and using established Loop-mediated Isothermal Amplification (LAMP) platform, ETEC [heat labile toxin (LT) and heat stable toxins (STh, and STp) genes] and Shigella (ipaH gene) detection was made simple, rapid (<50 minutes), and inexpensive. This assay is cold chain and electricity free. Moreover, RLDT requires minimal equipment. To avoid any end user's bias, a battery-operated, handheld reader was used to read the RLDT results. The results can be read as positive/negative or as real time amplification depending on the end user's need. The performance specifications of the RLDT assay, including analytical sensitivity and specificity, were evaluated using fecal samples spiked with ETEC and Shigella strains. The limit of detection was ~105 CFU/gm of stool for LT, STh, and STp and ~104 CFU/gm of stool for the ipaH gene, which corresponds to about 23 CFU and 1 CFU respectively for ETEC and Shigella per 25uL reaction within 40 minutes. The RLDT assay from stool collection to result is simple, and rapid and at the same time sufficiently sensitive. RLDT has the potential to be applied in resource poor endemic settings for the rapid diagnosis of ETEC and Shigella.

Indexed as

DNA, BacterialDysentery, BacillaryEnterotoxigenic Escherichia coliEscherichia coli InfectionsFecesHumansMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesShigellaDNA, Bacterial

Identifiers

PMID35089927
PMCPMC8827434
OpenAlexW4210807854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.